ELMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Electromed, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 25, 2026
$27.40−0.02 (-0.07%)
Close on Oct 19, 2026
- Market cap
- $239.32M
- P/E (TTM)
- 21.1
- Dividend yield
- –
Share price
+$3.11 (+12.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Electromed, Inc. grew revenue 15.3% to $73.78M over the twelve months to Jun 30, 2026. Operating income rose 43.7% to $13.88M, moving the operating margin from 15.1% to 18.8%. Free cash flow was $8.41M, down 24.4% from a year earlier.
Revenue
$73.78M
+15.3% vs. a year earlier
Operating income
$13.88M
+43.7% vs. a year earlier
Free cash flow
$8.41M
-24.4% vs. a year earlier
EPS, diluted
$1.30
+52.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $239.32M
- P/E ratio
- 21.1
- Price to sales
- 3.24
- Price to book
- 4.43
- Dividend yield
- –
- Free cash flow yield
- 3.52%
Fundamentals
- Revenue
- $73.78M
- Net income
- $11.30M
- EPS, diluted
- $1.30
- Free cash flow
- $8.41M
- Book value per share
- $6.18
- Diluted shares
- 9M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$73.78M+15.3% YoY
Gross profit
$57.94M+16.0% YoY
Operating income
$13.88M+43.7% YoY
Net income
$11.30M+49.9% YoY
EPS, diluted
$1.30+52.9% YoY
Free cash flow
$8.41M-24.4% YoY
Reported period